The clinical significance of endotoxin released by antibiotics: What is the evidence?

Journal of Endotoxin Research

Volumn 3, Issue 3, 1996, Pages 253-259

  Mock, C N ^a,c   Jurkovich, G J ^a   Dries, D ^b   Maier, R V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN; ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ENDOTOXIN; GAMMA INTERFERON; GENTAMICIN; PENICILLIN G; PLACEBO; TUMOR NECROSIS FACTOR;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; GRAM NEGATIVE INFECTION; HUMAN; INJURY; MORTALITY; NONHUMAN; SEPTIC SHOCK;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0029776728     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300311     Document Type: Conference Paper

References (37)

1. Arditi M., Kabat W., Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis 1993; 167: 240-244.
2. Dofferhoff A.S.M., Nijland J.H., deVries-Hospers H.G. et al. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an invitro and in-vivo study. Scand J Infect Dis 1991; 23: 745-754.
3. Eng R.H.K., Smith S.M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185-189.
4. Friedland I.R., Jafari H., Ehret S. et al. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis 1993; 168: 657-662.
5. Georgopapadakou N.H. Penicillin-binding proteins and bacterial resistance to β-lactams. Antimicrob Agents Chemother 1993; 37: 2045-2053.
6. Hurley J.C., Louis W.J., Tosolini F.A., Carlin J.B. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob Agents Chemother 1991; 35: 2388-2394.
7. Hurley J.C. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840-854.
8. Jackson J.J., Kropp H. β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
9. Mellado M.C., Rodriguez-Contreras A., Mariscal A. et al. Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis. Epidemiol Infect 1991; 106: 283-288.
10. Neu H.C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med 1985; 79 (Suppl 2A): 2-13.
11. Sawyer R.G., Adams R.B., May A.K., Rosenlof I.K., Pruett T.L. Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release. Arch Surg 1993; 128: 73-78.
12. Shenep J.L., Barton R.P., Morgan K.A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012-1018.
13. Simon D.M., Koenig G., Trenholme G.M. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis 1991; 164: 800-802.
14. Tuomanen E., Gilbert K., Tomasz A. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob Agents Chemother 1986; 30: 659-663.
15. VandenBerg C.A., DeNeeling A.J., Schot C.S. et al. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24: 619-627.
16. Hurley J.C. Antibiotic-induced release of endotoxin: a therapeutic paradox. Drug Safety 1995; 12: 183-195.
17. Prins J.M., vanDeventer S.J.H., Kuijper E.J., Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-1218.
18. Neu H.C. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death. Am J Med 1983; 75 (Suppl 2A): 9-20.
19. Bucklin S.E., Fujihara Y., Leeson M.C., Morrison D.C. Differential antibiotic-induced release of endotoxin from gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl. 1): 43-51.
20. Jarisch A. Therapeutische Veruche bei Syphilis. Wien Med Wochenschr 1895; 45: 721-724.
21. Gelfand J.A., Elin R.J., Berry F.W., Frank M.M. Endotoxemia associated with the Jarisch-Herxheimer. N Engl J Med 1976; 295: 211-213.
22. Bryceson A., Cooper K.E., Warrell D.A. et al. Studies on the mechanisms of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin. Clin Sci 1972; 43: 343-354.
23. Galloway R.E., Levin J., Butler T. et al. Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection. Am J Med 1977; 63: 933-938.
24. Negussie Y., Remick D.G., DeForge L.E. et al. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer reaction of relapsing fever. J Exp Med 1992; 175: 1207-1212.
25. Watt G., Padre L.P., Tuazon M., Calubaquib C. Limulus lysate positivity and Herxheimer-like reactions in leptospirosis: a placebo-controlled study. J Infect Dis 1990; 162: 564-567.
26. Shenep J.L., Feldman S., Thornton D. Evaluation for endotoxemia in patients receiving penicillin therapy for secondary syphilis. JAMA 1986; 256: 388-390.
27. Young E.J., Weingarten N.M., Baughn R.E., Duncan W.C. Studies on the pathogenesis of the Jarisch-Herxheimer reaction: development of an animal model and evidence against a role for classical endotoxin. J Infect Dis 1982; 146: 606-615.
28. Patel J.C., Banker D.D., Modi C.J. Chloramphenicol in typhoid fever. BMJ 1949; ii: 908-909.
29. Hopkin D.A.B. Frapper fort ou frapper doucement: a gramnegative dilemma. Lancet 1978; ii: 1193-1194.
30. Brandtzaeg P., Kierulf P., Gaustad P. et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
31. Engebretsen L.F., Kierulf P., Brandtzaeg P. Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb Res 1986; 42: 713-716.
32. Shenep J.L., Flynn P.M., Barret F.F., Stidham G.L., Westenkirchner D.F. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 1988; 157: 565-568.
33. Arditi M., Abies L., Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis 1989; 160: 1005-1011.
34. Prins J.M., van Agtmael M.A., Kuijper E.J., van Deventer S.J.H., Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
35. Mock C.N., Jurkovich G.J., Dries D.J., Maier R.V. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 1995; 130: 1234-1241.
36. Dries D.J., Jurkovich G.J., Maier R.V. et al. Effect of interferon-gamma on infection-related death in patients with severe injuries. Arch Surg 1994; 129: 1031-1041.
37. Jurkovich G.J., Mileski W.J., Maier R.V., Winn R.K., Rice C.L. Interferon gamma increases sensitivity to endotoxin. J Surg Res 1991; 51: 197-203.